Recurrent SETBP1 mutations in atypical chronic myeloid leukemia por Piazza, R, Valletta, S, Winkelmann, N, Winkelmann, N, Redaelli, S, Spinelli, R, Pirola, A, Antolini, L, Mologni, L, Donadoni, C, Papaemmanuil, E, Schnittger, S, Kim, D, Boultwood, J, Rossi, F, Gaipa, G, De Martini, G, Di Celle, P, Jang, H, Jang, H, Fantin, V, Fantin, V, Bignell, G, Magistroni, V, Haferlach, T

Recurrent SETBP1 mutations in atypical chronic myeloid leukemia. por Piazza, R, Valletta, S, Winkelmann, N, Redaelli, S, Spinelli, R, Pirola, A, Antolini, L, Mologni, L, Donadoni, C, Papaemmanuil, E, Schnittger, S, Kim, D, Boultwood, J, Rossi, F, Gaipa, G, De Martini, G, di Celle, P, Jang, H, Fantin, V, Bignell, G, Magistroni, V, Haferlach, T, Pogliani, E, Campbell, P, Chase, A

De novo UBE2A mutations are recurrently acquired during chronic myeloid leukemia progression and interfere with myeloid differentiation pathways por Magistroni, V, Mauri, M, D'Aliberti, D, Mezzatesta, C, Crespiatico, I, Nava, M, Fontana, D, Sharma, N, Parker, W, Schreiber, A, Yeung, D, Pirola, A, Redaelli, S, Massimino, L, Wang, P, Khandelwal, P, Citterio, S, Viltadi, M, Bombelli, S, Rigolio, R, Perego, R, Boultwood, J, Morotti, A, Saglio, G, Kim, D, Branford, S, Gambacorti-Passerini, C, Piazza, R